AI Article Synopsis

  • A study investigated diabetes risk factors and glucose tolerance in 106 women with Turner Syndrome (TS), revealing that a significant portion presented with normal glucose tolerance, while a smaller percentage had impaired glucose tolerance (IGT) or diabetes mellitus (DM).
  • The research found no link between autoimmune markers and DM, but noted that women with IGT or DM were generally older and had higher body mass indices and insulin resistance.
  • The findings suggest that TS-related DM shares characteristics of both type 1 and type 2 diabetes, with weight and insulin resistance being key factors; assessing specific markers may help predict future insulin needs.

Article Abstract

Context: Diabetes mellitus (DM) risk factors in Turner Syndrome (TS) may include autoimmunity, obesity, beta-cell dysfunction, genetic predisposition and insulin resistance (IR).

Objective: Evaluate glucose tolerance and DM risk factors in adults with TS.

Design: A single centre study with two phases. To determine the prevalence of DM and to assess diabetes risk markers comparing women with TS with and without impaired glucose tolerance (IGT).

Setting: Tertiary referral center, University College Hospitals.

Patients: 106 Women with TS (age range 18-70 years) undergoing annual health surveillance.

Interventions: Participants underwent oral glucose tolerance tests (OGTT), with additional samples for autoimmunity and genetic analysis.

Main Outcome Measure: Glucose tolerance, insulin, autoimmune and single nucleotide polymorphism (SNP) profile.

Results: OGTT screening showed that those without a previous DM diagnosis, 72.7% had normal glucose tolerance, 19.5% had IGT, and 7.6% were newly diagnosed with DM. OGTT identified more cases of DM than HbAc1 sampling alone. Women with IGT or DM were older, with higher body mass index and IR. No association was found between autoimmune markers GAD, IA-2 and ZnT8, risk karyotypes or selected SNPs and DM. In DM cases, GAD positivity was associated with requirement for insulin therapy. The median age of onset of the diagnosis of DM was 36 years (range 11-56).

Conclusions: In the spectrum of DM subtypes, TS-associated DM lies between type 1 and type 2 DM with features of both. Key factors include weight and IR. Assessing C-peptide or GAD antibodies may aid future insulin requirement.

Download full-text PDF

Source
http://dx.doi.org/10.1210/clinem/dgae357DOI Listing

Publication Analysis

Top Keywords

glucose tolerance
20
diabetes mellitus
8
risk factors
8
glucose
5
tolerance
5
characterization turner
4
turner syndrome-associated
4
syndrome-associated diabetes
4
mellitus context
4
context diabetes
4

Similar Publications

Metabolic changes that allow artemisinin-resistant parasites to tolerate oxidative stress.

Front Parasitol

September 2024

Centro de Cálculo Científico de la Universidad de Los Andes (CeCalCULA), Universidad de Los Andes (ULA), Mérida, Venezuela.

Artemisinin-based treatments (ACTs) are the first therapy currently used to treat malaria produced by . However, in recent years, increasing evidence shows that some strains of are less susceptible to ACT in the Southeast Asian region. A data reanalysis of several omics approaches currently available about parasites of that have some degree of resistance to ACT was carried out.

View Article and Find Full Text PDF

Defining metabolic health is critical for the earlier reversing of metabolic dysfunction and disease, and fasting-based diagnosis may not adequately assess an individual's metabolic adaptivity under stress. We constructed a novel Health State Map (HSM) comprising a Health Phenotype Score (HPS) with fasting features alone and a Homeostatic Resilience Score (HRS) with five time-point features only ( = 30, 60, 90, 180, 240 min) following a standardized mixed macronutrient tolerance test (MMTT). Among 111 Chinese adults, when the same set of fasting and post-MMTT data as for the HSM was used, the mixed-score was highly correlated with the HPS.

View Article and Find Full Text PDF

Background Sodium-glucose co-transporter 2 (SGLT2) inhibitors are an emerging treatment for type 2 diabetes mellitus (T2DM). The effect and tolerability of SGLT2 inhibitors in patients with T2DM, especially related risk factors and susceptible populations, are an area of ongoing research. Aim The aim of this study was to evaluate the tolerability of SGLT2 inhibitors, particularly the risk associated with urogenital infection, in patients with T2DM.

View Article and Find Full Text PDF

Pancreatic expression of CPT1A is essential for whole body glucose homeostasis by supporting glucose-stimulated insulin secretion.

J Biol Chem

January 2025

Laboratory of Immunogenetics, Pennington Biomedical Research Center, Baton Rouge, LA, 70808, USA; Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. Electronic address:

Pancreatic islet β-cells express the Cpt1a gene, which encodes the enzyme carnitine palmitoyltransferase 1A (CPT1A), an enzyme that facilitates entry of long chain fatty acids into the mitochondria. Because fatty acids are required for glucose-stimulated insulin secretion, we tested the hypothesis that CPT1A is essential to support islet β-cell function and mass. In this study, we describe genetic deletion of Cpt1a in pancreatic tissue (Cpt1a) using C57BL/6J mice.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!